Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2024

BUY
$0.72 - $1.21 $61,927 - $104,072
86,010 New
86,010 $66.1 Million
Q1 2023

May 15, 2023

BUY
$0.72 - $1.21 $43,336 - $72,829
60,190 Added 233.11%
86,010 $66,000
Q4 2022

May 10, 2024

SELL
$0.82 - $1.36 $50,083 - $83,066
-61,078 Reduced 70.29%
25,820 $23,000
Q4 2022

Jun 14, 2023

SELL
$0.82 - $1.36 $49,355 - $81,858
-60,190 Reduced 69.98%
25,820 $23,000
Q4 2022

Mar 22, 2023

SELL
$0.82 - $1.36 $50,083 - $83,066
-61,078 Reduced 70.29%
25,820 $23,000
Q4 2022

Feb 15, 2023

SELL
$0.82 - $1.36 $50,083 - $83,066
-61,078 Reduced 70.29%
25,820 $23,000
Q3 2022

May 10, 2024

BUY
$0.91 - $2.27 $11,322 - $28,243
12,442 Added 16.71%
86,898 $80,000
Q3 2022

Jun 14, 2023

BUY
$0.91 - $2.27 $808 - $2,015
888 Added 1.03%
86,898 $80,000
Q3 2022

Mar 22, 2023

BUY
$0.91 - $2.27 $11,322 - $28,243
12,442 Added 16.71%
86,898 $80,000
Q3 2022

Nov 14, 2022

BUY
$0.91 - $2.27 $11,322 - $28,243
12,442 Added 16.71%
86,898 $81,000
Q2 2022

May 10, 2024

BUY
$1.5 - $2.57 $25,615 - $43,887
17,077 Added 29.76%
74,456 $158,000
Q2 2022

Jun 20, 2023

SELL
$1.5 - $2.57 $17,331 - $29,693
-11,554 Reduced 13.43%
74,456 $158,000
Q2 2022

Mar 22, 2023

BUY
$1.5 - $2.57 $25,615 - $43,887
17,077 Added 29.76%
74,456 $158,000
Q2 2022

Aug 11, 2022

BUY
$1.5 - $2.57 $25,615 - $43,887
17,077 Added 29.76%
74,456 $159,000
Q1 2022

May 10, 2024

BUY
$1.99 - $3.0 $114,184 - $172,137
57,379 New
57,379 $133,000
Q1 2022

Jun 20, 2023

SELL
$1.99 - $3.0 $56,975 - $85,893
-28,631 Reduced 33.29%
57,379 $133,000
Q1 2022

Mar 22, 2023

SELL
$1.99 - $3.0 $1,609 - $2,427
-809 Reduced 1.39%
57,379 $133,000
Q1 2022

May 12, 2022

SELL
$1.99 - $3.0 $1,609 - $2,427
-809 Reduced 1.39%
57,379 $133,000
Q4 2021

May 17, 2024

BUY
$2.14 - $3.31 $57,420 - $88,813
26,832 Added 85.57%
58,188 $179,000
Q4 2021

Jun 21, 2023

SELL
$2.14 - $3.31 $59,539 - $92,090
-27,822 Reduced 32.35%
58,188 $179,000
Q4 2021

Mar 22, 2023

BUY
$2.14 - $3.31 $57,420 - $88,813
26,832 Added 85.57%
58,188 $179,000
Q4 2021

Feb 15, 2022

BUY
$2.14 - $3.31 $57,420 - $88,813
26,832 Added 85.57%
58,188 $180,000
Q3 2021

May 17, 2024

SELL
$2.86 - $4.21 $75,758 - $111,518
-26,489 Reduced 45.79%
31,356 $92,000
Q3 2021

Jun 21, 2023

SELL
$2.86 - $4.21 $156,310 - $230,093
-54,654 Reduced 63.54%
31,356 $92,000
Q3 2021

Mar 22, 2023

SELL
$2.86 - $4.21 $75,758 - $111,518
-26,489 Reduced 45.79%
31,356 $92,000
Q3 2021

Nov 15, 2021

SELL
$2.86 - $4.21 $75,758 - $111,518
-26,489 Reduced 45.79%
31,356 $93,000
Q2 2021

May 17, 2024

BUY
$3.21 - $5.62 $185,682 - $325,088
57,845 New
57,845 $267,000
Q2 2021

Jun 21, 2023

SELL
$3.21 - $5.62 $90,409 - $158,287
-28,165 Reduced 32.75%
57,845 $267,000
Q2 2021

Mar 22, 2023

BUY
$3.21 - $5.62 $7,071 - $12,380
2,203 Added 3.96%
57,845 $267,000
Q2 2021

Aug 16, 2021

BUY
$3.21 - $5.62 $185,682 - $325,088
57,845 New
57,845 $268,000
Q4 2019

Feb 14, 2020

SELL
$0.82 - $2.24 $45,626 - $124,638
-55,642 Closed
0 $0
Q3 2019

Jul 12, 2023

SELL
$1.36 - $2.4 $41,300 - $72,883
-30,368 Reduced 35.31%
55,642 $125,000
Q2 2019

Jul 12, 2023

SELL
$1.73 - $2.37 $52,536 - $71,972
-30,368 Reduced 35.31%
55,642 $116,000
Q1 2019

Jul 13, 2023

SELL
$1.71 - $2.85 $51,929 - $86,548
-30,368 Reduced 35.31%
55,642 $95,000
Q4 2018

Jul 13, 2023

SELL
$2.15 - $3.11 $65,291 - $94,444
-30,368 Reduced 35.31%
55,642 $138,000
Q4 2018

Mar 22, 2023

BUY
$2.15 - $3.11 $64,117 - $92,746
29,822 Added 115.5%
55,642 $138,000
Q4 2018

Feb 14, 2019

BUY
$2.15 - $3.11 $119,630 - $173,046
55,642 New
55,642 $139,000
Q3 2018

Nov 14, 2018

SELL
$2.28 - $2.93 $134,048 - $172,263
-58,793 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$2.02 - $2.55 $118,761 - $149,922
58,793 New
58,793 $145,000

Others Institutions Holding XXII

About 22nd Century Group, Inc.


  • Ticker XXII
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Tobacco
  • Shares Outstandng 214,784,992
  • Market Cap $19.3M
  • Description
  • 22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King n...
More about XXII
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.